Amphastar Pharmaceuticals (NASDAQ: AMPH) net income
Amphastar Pharmaceuticals reported a net profit of $98.1m for fiscal 2025, 38.5% less than in fiscal 2024 ($159.5m). Its net margin was 13.6%. Earnings per share were $2.10.
Amphastar Pharmaceuticals's best year of the last 10 was fiscal 2024. The biggest drop was in fiscal 2020, −97.1%. It reported a loss in 1 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $98.1m | −38.5% | 13.6% | $2.10 |
| 2024 | $159.5m | +16.0% | 21.8% | $3.29 |
| 2023 | $137.5m | +50.5% | 21.3% | $2.85 |
| 2022 | $91.4m | +47.1% | 18.3% | $1.88 |
| 2021 | $62.1m | +4,327.4% | 14.2% | $1.30 |
| 2020 | $1.4m | −97.1% | 0.4% | $0.03 |
| 2019 | $48.9m | — | 15.2% | $1.04 |
| 2018 | −$5.7m | −257.3% | −1.9% | −$0.12 |
| 2017 | $3.6m | −62.9% | 1.5% | $0.08 |
| 2016 | $9.8m | — | 3.8% | $0.22 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Amphastar Pharmaceuticals net income compared with its sector
By net income for its latest fiscal year, Amphastar Pharmaceuticals ranks 113th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Amphastar Pharmaceuticals, 13.6%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 111th | Integer | $102.8m | 5.5% |
| 112th | Phibro Animal Health | $99.7m | 6.6% |
| 113th | Amphastar Pharmaceuticals | $98.1m | 13.6% |
| 114th | Haemonetics | $97.3m | 7.3% |
| 115th | Addus HomeCare | $95.9m | 6.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Amphastar Pharmaceuticals
- How much did Amphastar Pharmaceuticals earn in fiscal 2025?
- Amphastar Pharmaceuticals reported a net profit of $98.1m for fiscal 2025. In fiscal 2024 it reported a net profit of $159.5m.
- What are the earnings per share of Amphastar Pharmaceuticals?
- They were $2.10 in fiscal 2025, compared with $3.29 in fiscal 2024.
- What is the net margin of Amphastar Pharmaceuticals?
- In fiscal 2025 its net profit was 13.6% of its revenue.
- What was the most profitable year for Amphastar Pharmaceuticals?
- Of its last 10 fiscal years, fiscal 2024, with $159.5m.
- Where does Amphastar Pharmaceuticals rank in its sector by net income?
- It ranks 113th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Amphastar Pharmaceuticals come from?
- From the annual report (Form 10-K) that Amphastar Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Amphastar Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Amphastar Pharmaceuticals: the Amphastar Pharmaceuticals page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.